EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 P&L / Income Statement

EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

1,741,000,000 US dollars

Cost of sales

392,400,000 US dollars

Gross profit

1,348,600,000 US dollars

Operating costs, net of other operating income (calculated)

835,400,000 US dollars

Operating income, net

513,200,000 US dollars

Other income (expense), net (calculated)

6,600,000 US dollars

Income from continuing operations before provision for income taxes

519,800,000 US dollars

Provision for income taxes

278,400,000 US dollars

Net income

241,400,000 US dollars

United States

1,003,500,000 US dollars

Europe

439,600,000 US dollars

Japan

96,400,000 US dollars

Rest of World

201,500,000 US dollars

Selling, general, and administrative expenses

561,200,000 US dollars

Research and development expenses

278,900,000 US dollars

Certain litigation expenses

6,300,000 US dollars

Separation costs

0 US dollars

Other operating income

negative 11,000,000 US dollars

Loss from discontinued operations, net of tax

0 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
• Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $241.90 M; to noncontrolling interests: −$500.00 K.